SEOUL, South Korea--(BUSINESS WIRE)--On 28 March, Gencurix (KONEX:229000) announced that the results of clinical trials for the prediction of breast cancer prognosis were published in Scientific ...

In the modern era of advanced imaging and genomics testing, the digital rectal exam (DRE) is still an "important" and clinically relevant prognostic test for prostate cancer, conclude the authors of a ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, ...

SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc (MYGN). (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer ...

Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing Current guidelines for postoperative management of patients with stage I-IIA ...

Cancer is a leading cause of death worldwide, so there is an urgent need to define the molecular mechanisms driving the development and progression of individual tumors and identify a molecular ...

In this article, we will attempt to inform this debate by summarizing what is known about prognostic awareness (PA) in the adult advanced cancer and palliative care settings. We also review ...